Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Ewing sarcoma in patients over 40 years of age: a prospective analysis of 31 patients treated at a single institution.

Cesari M, Righi A, Cevolani L, Palmerini E, Vanel D, Donati DM, Cammelli S, Gambarotti M, Ferrari C, Paioli A, Longhi A, Abate ME, Picci P, Ferrari S.

Tumori. 2016 Oct 13;102(5):481-487. doi: 10.5301/tj.5000534. Epub 2016 Jul 18.

PMID:
27443894
2.

Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.

Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Juergens H, Kolb HJ, Burdach SE.

Oncotarget. 2016 Oct 25;7(43):70959-70968. doi: 10.18632/oncotarget.10938.

3.

Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

Tural D, Molinas Mandel N, Dervisoglu S, Oner Dincbas F, Koca S, Colpan Oksuz D, Kantarci F, Turna H, Selcukbiricik F, Hiz M.

Jpn J Clin Oncol. 2012 May;42(5):420-6. doi: 10.1093/jjco/hys027. Epub 2012 Mar 12.

PMID:
22416252
4.

Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study.

Ferrari S, Palmerini E, Alberghini M, Staals E, Mercuri M, Barbieri E, Longhi A, Cantero L, Cesari M, Abate M, Balladelli A, Picci P, Bacci G.

Tumori. 2010 Mar-Apr;96(2):213-8.

PMID:
20572576
5.

Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.

Raciborska A, Bilska K, Drabko K, Chaber R, Sobol G, Pogorzała M, Wyrobek E, Połczyńska K, Rogowska E, Rodriguez-Galindo C, Wożniak W.

Pediatr Blood Cancer. 2014 Dec;61(12):2170-4. doi: 10.1002/pbc.25167. Epub 2014 Aug 27.

PMID:
25163763
6.

Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.

Takenaka S, Naka N, Obata H, Joyama S, Hamada K, Imura Y, Kakunaga S, Aoki Y, Ueda T, Araki N, Yoshikawa H.

Jpn J Clin Oncol. 2016 Jun;46(6):522-8. doi: 10.1093/jjco/hyw032. Epub 2016 Mar 23.

PMID:
27008849
7.

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jürgens H.

J Clin Oncol. 2010 Jul 10;28(20):3284-91. doi: 10.1200/JCO.2009.22.9864. Epub 2010 Jun 14.

PMID:
20547982
8.

Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.

Paioli A, Luksch R, Fagioli F, Tamburini A, Cesari M, Palmerini E, Abate ME, Marchesi E, Balladelli A, Pratelli L, Ferrari S.

J Chemother. 2014 Feb;26(1):49-56. doi: 10.1179/1973947813Y.0000000103. Epub 2013 Dec 6.

PMID:
24091100
9.

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.

Ferrari S, Sundby Hall K, Luksch R, Tienghi A, Wiebe T, Fagioli F, Alvegard TA, Brach Del Prever A, Tamburini A, Alberghini M, Gandola L, Mercuri M, Capanna R, Mapelli S, Prete A, Carli M, Picci P, Barbieri E, Bacci G, Smeland S.

Ann Oncol. 2011 May;22(5):1221-7. doi: 10.1093/annonc/mdq573. Epub 2010 Nov 8.

PMID:
21059639
10.

Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.

Brunetto AL, Castillo LA, Petrilli AS, Macedo CD, Boldrini E, Costa C, Almeida MT, Kirst D, Rodriguez-Galindo C, Pereira WV, Watanabe FM, Pizza M, Benites E, Morais V, Gadelha A, Nakasato A, Abujamra AL, Gregianin LJ; Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors EWING1 and the Brazilian Society of Pediatric Oncology SOBOPE.

Pediatr Blood Cancer. 2015 Oct;62(10):1747-53. doi: 10.1002/pbc.25562. Epub 2015 Apr 27.

PMID:
25917418
11.

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG.

Cancer. 2011 Jul 1;117(13):3027-32. doi: 10.1002/cncr.25840. Epub 2011 Jan 10.

12.

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R, Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Juergens H, Craft A, Oberlin O, Dirksen U.

J Clin Oncol. 2014 Aug 10;32(23):2440-8. doi: 10.1200/JCO.2013.54.4833. Epub 2014 Jun 30.

PMID:
24982464
13.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR.

J Clin Oncol. 2012 Nov 20;30(33):4148-54. doi: 10.1200/JCO.2011.41.5703. Epub 2012 Oct 22. Erratum in: J Clin Oncol. 2015 Mar 1;33(7):814. Dosage error in article text.

14.

Extraskeletal Ewing sarcoma of the abdominal wall.

Askri A, Farhat LB, Ghariani B, Rabeh A, Dali N, Said W, Hendaoui L.

Cancer Imaging. 2008 Sep 10;8:156-8. doi: 10.1102/1470-7330.2008.0023.

15.

Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Mohanti BK, Sharma MC, Vishnubhatla S, Bakhshi S.

J Surg Oncol. 2015 May;111(6):683-9. doi: 10.1002/jso.23861. Epub 2014 Dec 29.

PMID:
25557999
16.

Prognostic factors in head and neck Ewing sarcoma family of tumors.

Biswas B, Thakar A, Mohanti BK, Vishnubhatla S, Bakhshi S.

Laryngoscope. 2015 Mar;125(3):E112-7. doi: 10.1002/lary.24985. Epub 2014 Oct 27.

PMID:
25345585
17.

Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.

PMID:
21184634
18.

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.

Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H; European Intergroup Cooperative Ewing's Sarcoma Study-92.

J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720.

PMID:
18802150
19.

Primary cutaneous and subcutaneous Ewing sarcoma.

Di Giannatale A, Frezza AM, Le Deley MC, Marec-Bérard P, Benson C, Blay JY, Bui B, Judson I, Oberlin O, Whelan J, Gaspar N.

Pediatr Blood Cancer. 2015 Sep;62(9):1555-61. doi: 10.1002/pbc.25535. Epub 2015 Apr 20.

PMID:
25894676
20.

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G, et al.

J Clin Oncol. 1995 Nov;13(11):2796-804.

PMID:
7595741

Supplemental Content

Support Center